Matches in SemOpenAlex for { <https://semopenalex.org/work/W3183219963> ?p ?o ?g. }
- W3183219963 endingPage "6610" @default.
- W3183219963 startingPage "6605" @default.
- W3183219963 abstract "Objective: To investigate the small intestinal bacterial overgrowth (SIBO) and to evaluate the intestinal barrier function in ulcerative colitis (UC) patients treated with mesalazine and rifaximin. Methods: 96 patients undergoing the methane-hydrogen breath test in our hospital from January 2018 to January 2020 were enrolled in the study group, and 40 healthy persons were enrolled in the control group during this period. The SIBO positive rate of the two groups were collected and compared. Then, the SIBO positive patients were divided into group A and group B. Group A and group B all received mesalazine, and group B received rifaximin plus. The clinical efficacy, erythrocyte sedimentation rate (ESR), C reactive protein (CRP), and intestinal barrier function indexes like diamine oxidase (DAO) and D-lactic acid (DLA) were recorded and compared. Results: The study group presented higher SIBO positive rate compared with the control group (56% vs. 25%, P<0.05). After treatment, group B showed better clinical efficacy and lower levels of ESR and CRP than group A (all P<0.05). After treatment, the DAO and D-LA levels of the two groups were decreased, and presented lower levels in group B than group A (all P<0.05). Conclusion: UC patients present a higher positive rate in SIBO. Mesalazine and rifaximin are applied to patients with mild to moderate UC, and their clinical efficacy has been significantly enhanced after the eradication of SIBO." @default.
- W3183219963 created "2021-08-02" @default.
- W3183219963 creator A5015106715 @default.
- W3183219963 creator A5037677450 @default.
- W3183219963 creator A5071057421 @default.
- W3183219963 creator A5086607379 @default.
- W3183219963 creator A5087335378 @default.
- W3183219963 date "2021-06-15" @default.
- W3183219963 modified "2023-09-26" @default.
- W3183219963 title "Small intestinal bacterial overgrowth and evaluation of intestinal barrier function in patients with ulcerative colitis." @default.
- W3183219963 cites W2074080336 @default.
- W3183219963 cites W2097495558 @default.
- W3183219963 cites W2774339715 @default.
- W3183219963 cites W2895590704 @default.
- W3183219963 cites W2902316223 @default.
- W3183219963 cites W2938555453 @default.
- W3183219963 cites W2947971523 @default.
- W3183219963 cites W2978092385 @default.
- W3183219963 cites W2983532316 @default.
- W3183219963 cites W2996739906 @default.
- W3183219963 cites W2997391968 @default.
- W3183219963 cites W2998923625 @default.
- W3183219963 cites W2999072673 @default.
- W3183219963 cites W2999958129 @default.
- W3183219963 cites W3000459179 @default.
- W3183219963 cites W3011068480 @default.
- W3183219963 cites W3012120275 @default.
- W3183219963 cites W3024035917 @default.
- W3183219963 cites W3026344944 @default.
- W3183219963 cites W3029057374 @default.
- W3183219963 cites W3036426552 @default.
- W3183219963 cites W3046050014 @default.
- W3183219963 cites W3087180779 @default.
- W3183219963 cites W3089212856 @default.
- W3183219963 cites W3092485793 @default.
- W3183219963 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8290731" @default.
- W3183219963 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34306403" @default.
- W3183219963 hasPublicationYear "2021" @default.
- W3183219963 type Work @default.
- W3183219963 sameAs 3183219963 @default.
- W3183219963 citedByCount "9" @default.
- W3183219963 countsByYear W31832199632022 @default.
- W3183219963 countsByYear W31832199632023 @default.
- W3183219963 crossrefType "journal-article" @default.
- W3183219963 hasAuthorship W3183219963A5015106715 @default.
- W3183219963 hasAuthorship W3183219963A5037677450 @default.
- W3183219963 hasAuthorship W3183219963A5071057421 @default.
- W3183219963 hasAuthorship W3183219963A5086607379 @default.
- W3183219963 hasAuthorship W3183219963A5087335378 @default.
- W3183219963 hasConcept C126322002 @default.
- W3183219963 hasConcept C181199279 @default.
- W3183219963 hasConcept C2778143017 @default.
- W3183219963 hasConcept C2778271842 @default.
- W3183219963 hasConcept C2778889925 @default.
- W3183219963 hasConcept C2779053737 @default.
- W3183219963 hasConcept C2779134260 @default.
- W3183219963 hasConcept C2779174533 @default.
- W3183219963 hasConcept C2780479503 @default.
- W3183219963 hasConcept C2780999109 @default.
- W3183219963 hasConcept C501593827 @default.
- W3183219963 hasConcept C55493867 @default.
- W3183219963 hasConcept C71924100 @default.
- W3183219963 hasConcept C86803240 @default.
- W3183219963 hasConcept C89423630 @default.
- W3183219963 hasConcept C90924648 @default.
- W3183219963 hasConceptScore W3183219963C126322002 @default.
- W3183219963 hasConceptScore W3183219963C181199279 @default.
- W3183219963 hasConceptScore W3183219963C2778143017 @default.
- W3183219963 hasConceptScore W3183219963C2778271842 @default.
- W3183219963 hasConceptScore W3183219963C2778889925 @default.
- W3183219963 hasConceptScore W3183219963C2779053737 @default.
- W3183219963 hasConceptScore W3183219963C2779134260 @default.
- W3183219963 hasConceptScore W3183219963C2779174533 @default.
- W3183219963 hasConceptScore W3183219963C2780479503 @default.
- W3183219963 hasConceptScore W3183219963C2780999109 @default.
- W3183219963 hasConceptScore W3183219963C501593827 @default.
- W3183219963 hasConceptScore W3183219963C55493867 @default.
- W3183219963 hasConceptScore W3183219963C71924100 @default.
- W3183219963 hasConceptScore W3183219963C86803240 @default.
- W3183219963 hasConceptScore W3183219963C89423630 @default.
- W3183219963 hasConceptScore W3183219963C90924648 @default.
- W3183219963 hasIssue "6" @default.
- W3183219963 hasOpenAccess W3183219963 @default.
- W3183219963 hasRelatedWork W1996633090 @default.
- W3183219963 hasRelatedWork W2064207211 @default.
- W3183219963 hasRelatedWork W2370461089 @default.
- W3183219963 hasRelatedWork W2382965758 @default.
- W3183219963 hasRelatedWork W2384830745 @default.
- W3183219963 hasRelatedWork W2386090982 @default.
- W3183219963 hasRelatedWork W2393663692 @default.
- W3183219963 hasRelatedWork W2396579552 @default.
- W3183219963 hasRelatedWork W3028605810 @default.
- W3183219963 hasRelatedWork W3029128617 @default.
- W3183219963 hasRelatedWork W3029487568 @default.
- W3183219963 hasRelatedWork W3029679773 @default.
- W3183219963 hasRelatedWork W3029990274 @default.
- W3183219963 hasRelatedWork W3030153737 @default.
- W3183219963 hasRelatedWork W3030992568 @default.